Skip to content

CTEV CTEV Total Equity

Total Equity at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$396.39M-57.6%
Corvel logo
CorvelCRVL
$394.23M+22.4%
ROP
Roper Technologies, Inc.ROP
$18.82B-2.1%
Cognizant logo
CognizantCTSH
$15.07B+1.1%
Phreesia logo
PhreesiaPHR
$359.09M+27.3%
UnitedHealth Group logo
UnitedHealth GroupUNH

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B
P/S0.6×

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by CTEV in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's total equity?
CTEV (CTEV) reported total equity of -$241.14M in Q1 2026.
How has CTEV's total equity changed year-over-year?
CTEV's total equity decreased by 1726.6% year-over-year, from $14.83M to -$241.14M.
What is the long-term trend for CTEV's total equity?
Over 5 years (2020 to 2025), CTEV's total equity has grown at a -41.6% compound annual growth rate (CAGR), from $2.56B to -$173.9M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.